USF Health, Weill Cornell Medicine Earn Inaugural Funding in NIH’s Newly Launched Bridge2AI Initiative

NIH Common Fund’s Bridge2AI program is designed to use AI to tackle complex biomedical challenges. The University of South Florida is the lead institution on the project in collaboration with Weill Cornell Medicine and ten other institutions. The first year of the project includes $3.8 million from the NIH, with potentially $14 million subsequent funding over the following three years. Voice as a Biomarker of Health is being co-led by Olivier Elemento, PhD, a Metabolic Center member and Dr. Yaël Bensoussan, MD, from USF.

Read more here

Weill Cornell Medicine
Center for Metabolic Health
413 E 69th St, 6th Floor New York, NY 10021 Phone: (646) 962-6193